Vaccination against multiple HPV types.

作者: Elamin H. Elbasha , Alison P. Galvani

DOI: 10.1016/J.MBS.2005.05.004

关键词:

摘要: Vaccines against the most common human papillomavirus (HPV) types are currently under development. Epidemiologic data suggest that transmission dynamics of different HPV not independent. Some studies indicate interactions among synergistic, where infection with one type facilitates concurrent or subsequent another type. Other point to antagonistic interference types. Here we develop a mathematical model explore how these may either enhance diminish effectiveness vaccination programs designed reduce prevalence associated cervical cancer. We analyze local stability infection-free and boundary equilibria characterize conditions leading coexistence equilibrium. also illustrate results numerical simulations using realistic parameters. show if mass even included in vaccine.

参考文章(55)
E M de Villiers, Heterogeneity of the human papillomavirus group. Journal of Virology. ,vol. 63, pp. 4898- 4903 ,(1989) , 10.1128/JVI.63.11.4898-4903.1989
Robert M. May, Roy M. Anderson, Infectious Diseases of Humans: Dynamics and Control ,(1991)
R B Roden, N L Hubbert, R Kirnbauer, N D Christensen, D R Lowy, J T Schiller, Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. Journal of Virology. ,vol. 70, pp. 3298- 3301 ,(1996) , 10.1128/JVI.70.5.3298-3301.1996
Sunetra Gupta, Alison Galvani, The effects of host heterogeneity on pathogen population structure. Philosophical Transactions of the Royal Society B. ,vol. 354, pp. 711- 719 ,(1999) , 10.1098/RSTB.1999.0424
J. R. Gog, B. T. Grenfell, Dynamics and selection of many-strain pathogens Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 17209- 17214 ,(2002) , 10.1073/PNAS.252512799
Darron R Brown, Kenneth H Fife, Cosette M Wheeler, Laura A Koutsky, Lisa M Lupinacci, Radha Railkar, Gretchen Suhr, Eliav Barr, Anthony Dicello, Weili Li, Judith F Smith, Amha Tadesse, Kathrin U Jansen, Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine. Vaccine. ,vol. 22, pp. 2936- 2942 ,(2004) , 10.1016/J.VACCINE.2003.11.059
Toshiyuki Sasagawa, Hiroshi Yamazaki, Yu-Zhen Dong, Shin-ichirou Satake, Masaya Tateno, Masaki Inoue, Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions International Journal of Cancer. ,vol. 75, pp. 529- 535 ,(1998) , 10.1002/(SICI)1097-0215(19980209)75:4<529::AID-IJC7>3.0.CO;2-V
Sunetra Gupta, Neil Ferguson, Roy Anderson, Chaos, Persistence, and Evolution of Strain Structure in Antigenically Diverse Infectious Agents Science. ,vol. 280, pp. 912- 915 ,(1998) , 10.1126/SCIENCE.280.5365.912
Christy L. Nebesio, Ginat W. Mirowski, Tsu-Yi Chuang, Human papillomavirus: clinical significance and malignant potential International Journal of Dermatology. ,vol. 40, pp. 373- 379 ,(2001) , 10.1046/J.1365-4362.2001.01232.X